rs17708515

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002609.4(PDGFRB):​c.102C>T​(p.Val34Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00742 in 1,579,558 control chromosomes in the GnomAD database, including 401 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 49 hom., cov: 33)
Exomes 𝑓: 0.0070 ( 352 hom. )

Consequence

PDGFRB
NM_002609.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.989

Publications

7 publications found
Variant links:
Genes affected
PDGFRB (HGNC:8804): (platelet derived growth factor receptor beta) The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]
PDGFRB Gene-Disease associations (from GenCC):
  • acroosteolysis-keloid-like lesions-premature aging syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • myofibromatosis, infantile, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • basal ganglia calcification, idiopathic, 4
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • bilateral striopallidodentate calcinosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile myofibromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary progressive mucinous histiocytosis
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 5-150135817-G-A is Benign according to our data. Variant chr5-150135817-G-A is described in ClinVar as Benign. ClinVar VariationId is 473399.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.989 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0537 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002609.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PDGFRB
NM_002609.4
MANE Select
c.102C>Tp.Val34Val
synonymous
Exon 3 of 23NP_002600.1
PDGFRB
NM_001355016.2
c.-91C>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 22NP_001341945.1
PDGFRB
NM_001355017.2
c.-416C>T
5_prime_UTR_premature_start_codon_gain
Exon 3 of 23NP_001341946.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PDGFRB
ENST00000261799.9
TSL:1 MANE Select
c.102C>Tp.Val34Val
synonymous
Exon 3 of 23ENSP00000261799.4
PDGFRB
ENST00000520579.5
TSL:1
n.102C>T
non_coding_transcript_exon
Exon 3 of 23ENSP00000430026.1
PDGFRB
ENST00000517488.1
TSL:3
c.-91C>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 3ENSP00000429218.1

Frequencies

GnomAD3 genomes
AF:
0.0109
AC:
1656
AN:
152170
Hom.:
43
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00956
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0366
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0360
Gnomad SAS
AF:
0.0599
Gnomad FIN
AF:
0.0141
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000838
Gnomad OTH
AF:
0.00767
GnomAD2 exomes
AF:
0.0212
AC:
4649
AN:
219058
AF XY:
0.0198
show subpopulations
Gnomad AFR exome
AF:
0.00875
Gnomad AMR exome
AF:
0.0776
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0306
Gnomad FIN exome
AF:
0.0152
Gnomad NFE exome
AF:
0.000901
Gnomad OTH exome
AF:
0.0142
GnomAD4 exome
AF:
0.00703
AC:
10030
AN:
1427270
Hom.:
352
Cov.:
32
AF XY:
0.00793
AC XY:
5606
AN XY:
706806
show subpopulations
African (AFR)
AF:
0.00938
AC:
304
AN:
32400
American (AMR)
AF:
0.0723
AC:
2898
AN:
40086
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23626
East Asian (EAS)
AF:
0.0245
AC:
961
AN:
39304
South Asian (SAS)
AF:
0.0497
AC:
3964
AN:
79762
European-Finnish (FIN)
AF:
0.0154
AC:
803
AN:
52128
Middle Eastern (MID)
AF:
0.00305
AC:
17
AN:
5576
European-Non Finnish (NFE)
AF:
0.000381
AC:
417
AN:
1095476
Other (OTH)
AF:
0.0113
AC:
666
AN:
58912
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
411
822
1232
1643
2054
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0111
AC:
1683
AN:
152288
Hom.:
49
Cov.:
33
AF XY:
0.0125
AC XY:
934
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00991
AC:
412
AN:
41558
American (AMR)
AF:
0.0371
AC:
567
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.0361
AC:
187
AN:
5182
South Asian (SAS)
AF:
0.0593
AC:
286
AN:
4820
European-Finnish (FIN)
AF:
0.0141
AC:
150
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000838
AC:
57
AN:
68020
Other (OTH)
AF:
0.0109
AC:
23
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
82
164
246
328
410
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00386
Hom.:
8
Bravo
AF:
0.0125
Asia WGS
AF:
0.0630
AC:
219
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Infantile myofibromatosis;C1866182:Acroosteolysis-keloid-like lesions-premature aging syndrome;C3554321:Basal ganglia calcification, idiopathic, 4;C4225270:Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome (1)
-
-
1
Myeloproliferative disorder, chronic, with eosinophilia (1)
-
-
1
Myofibromatosis, infantile, 1 (1)
-
-
1
not provided (1)
-
-
1
PDGFRB-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
13
DANN
Benign
0.81
PhyloP100
0.99
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17708515; hg19: chr5-149515380; COSMIC: COSV55802652; COSMIC: COSV55802652; API